Launceston chickpea extended ad libitum consumption study

A cross-over trial of the effect of ad libitum supplementation of chickpeas in the diet on nutrient intake, physiologic or metabolic parameters, compared to an ad libitum diet only for the reduction in cardiovascular disease risk factors

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000604606

Enrollment

Registered

2005-10-06

Start date

2004-09-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sequential cross-over trial comparing the effects of a stated minimum amount of chickpeas per week (four 300g cans) with an unrestricted (usual) diet of the subject's choosing. Chickpea diet period was 12 weeks duration.

Study design

Allocation

Non-randomised trial

Intervention model

Crossover

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

30 Years to 70 Years

Healthy volunteers

Inclusion criteria

Middle-aged, healthy, recruited by newspaper advertisement who were willing to eat a chickpea supplemented diet for a 12 week period.

Exclusion criteria

Those on lipid-lowering or anti-diabetic medication; intolerant to chickpea or wheat.

Outcome results